Company / Operating Cash Flow per Share
TENAX THERAPEUTICS, INC. Operating Cash Flow per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.33
FY2025
5-year range
-$19.79 / -$0.33
FY2021-FY2025
Trend
+78.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 7 years, ranging from $-19.79 in FY2024 to $-0.33 in FY2016.
Based on SEC 10-K filings.
-4.33 in FY2025.
Declined from $-0.33 to $-4.33 over the past 9 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 78.1% year-over-year.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.33 | +78.1% |
| FY2024 | -$19.79 | -5909.6% |
| FY2016 | -$0.33 | +0.9% |
| FY2015 | -$0.33 | +87.0% |
| FY2014 | -$2.55 | +54.7% |
| FY2013 | -$5.63 | -1466.8% |
| FY2012 | -$0.36 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026